These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15359558)

  • 1. Alleviation of multiple abnormalities by galantamine treatment in two patients with dementia with Lewy bodies.
    Holm AC
    Am J Alzheimers Dis Other Demen; 2004; 19(4):215-8. PubMed ID: 15359558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case study in the treatment of dementia with Lewy bodies.
    Kaufer DI
    Acta Psychiatr Scand; 2004 Jul; 110(1):73-5; discussion 75-6. PubMed ID: 15180783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dementia with Lewy bodies. Clinical improvement under treatment with an acetylcholinesterase inhibitor].
    Omerovic M; Teipel SJ; Hampel T
    Nervenarzt; 2007 Sep; 78(9):1052-7. PubMed ID: 17492420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study.
    Edwards K; Royall D; Hershey L; Lichter D; Hake A; Farlow M; Pasquier F; Johnson S
    Dement Geriatr Cogn Disord; 2007; 23(6):401-5. PubMed ID: 17409748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pimavanserin Treatment for Psychosis in Patients with Dementia with Lewy Bodies: A Case Series.
    Rothenberg KG; McRae SG; Dominguez-Colman LM; Shutes-David A; Tsuang DW
    Am J Case Rep; 2023 Sep; 24():e939806. PubMed ID: 37775968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergent complications following donepezil switchover to galantamine in three cases of dementia with Lewy bodies.
    Bhanji NH; Gauthier S
    J Neuropsychiatry Clin Neurosci; 2005; 17(4):552-5. PubMed ID: 16387998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dementia with lewy bodies: therapeutic opportunities and pitfalls.
    Henriksen AL; St Dennis C; Setter SM; Tran JT
    Consult Pharm; 2006 Jul; 21(7):563-75. PubMed ID: 16934009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study.
    Rozzini L; Chilovi BV; Bertoletti E; Conti M; Delrio I; Trabucchi M; Padovani A
    Am J Alzheimers Dis Other Demen; 2007; 22(1):42-7. PubMed ID: 17534001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinesterase inhibitors in dementia with Lewy bodies: a comparative analysis.
    Bhasin M; Rowan E; Edwards K; McKeith I
    Int J Geriatr Psychiatry; 2007 Sep; 22(9):890-5. PubMed ID: 17265415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia.
    Aarsland D; Hutchinson M; Larsen JP
    Int J Geriatr Psychiatry; 2003 Oct; 18(10):937-41. PubMed ID: 14533126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic treatment expectations in the management of dementia with Lewy bodies.
    Kaufer DI
    Dement Geriatr Cogn Disord; 2004; 17 Suppl 1():32-9. PubMed ID: 14676467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients characteristics with cholinesterase inhibitor resistant hallucinations in dementia with Lewy bodies.
    Lebert F; Pasquier F
    J Neurol Neurosurg Psychiatry; 2007 Dec; 78(12):1415-6. PubMed ID: 17846112
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacotherapy of dementia with Lewy bodies.
    Fernandez HH; Wu CK; Ott BR
    Expert Opin Pharmacother; 2003 Nov; 4(11):2027-37. PubMed ID: 14596656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased dosage of donepezil for the management of behavioural and psychological symptoms of dementia in dementia with Lewy bodies.
    Manabe Y; Ino T; Yamanaka K; Kosaka K
    Psychogeriatrics; 2016 May; 16(3):202-8. PubMed ID: 26179411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study.
    Samuel W; Caligiuri M; Galasko D; Lacro J; Marini M; McClure FS; Warren K; Jeste DV
    Int J Geriatr Psychiatry; 2000 Sep; 15(9):794-802. PubMed ID: 10984725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and cognitive correlates of visual hallucinations in dementia with Lewy bodies.
    Cagnin A; Gnoato F; Jelcic N; Favaretto S; Zarantonello G; Ermani M; Dam M
    J Neurol Neurosurg Psychiatry; 2013 May; 84(5):505-10. PubMed ID: 23264688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of behavioural problems in dementia using a cholinesterase inhibitor: the ethical questions.
    Coulson BS; Fenner SG; Almeida OP
    Aust N Z J Psychiatry; 2002 Apr; 36(2):259-62. PubMed ID: 11982550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholinesterase inhibitors for vascular dementia and Alzheimer's disease combined with cerebrovascular disease.
    Bowler JV
    Stroke; 2003 Feb; 34(2):584-6. PubMed ID: 12574580
    [No Abstract]   [Full Text] [Related]  

  • 20. Cognitive impairment in Parkinson's disease and dementia with Lewy bodies.
    Aarsland D
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S144-8. PubMed ID: 26411499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.